Advances in neoadjuvant immunotherapy for non-small cell lung cancer
Non-small cell lung cancer (NSCLC) represents the majority of lung cancer cases and remains a leading cause of cancer-related mortality worldwide. Early-stage NSCLC is primarily treated with surgical resection; however, high recurrence and metastasis r…